Founded in 2020, Capstan Medical is creating a new standard for minimally invasive, heart valve intervention. The company is developing a suite of next-generation heart valve implants and a first-of-its-kind catheter-based robotic delivery platform.
Date | Amount | Type | Investors | Valuation |
---|---|---|---|---|
12/11/24 | $110,000,000 | Series C |
Eclipse Ventures Gideon Strategic Partners Intuitive Ventures Yu Galaxy | undisclosed |